Ip, J., Brady, P., et al. (2024, May 16-19). Leadless vs. Transvenous Single-Chamber Ventricular Pacemakers: Real-World Evidence from Aveir™ VR Coverage with Evidence Development (CED) Study [Poster Presentation]. HRS 2024, Boston, MA, United States. Poster Session III-1715873549040.pdf (heartrhythmjournal.com)
AVEIR Leadless Pacemakers and Delivery Catheter IFU. ARTEN600331825.
Neuzil, Petr, et al. “Worldwide Chronic Retrieval Experience of Helix-Fixation Leadless Cardiac Pacemakers.” Journal of the American College of Cardiology, 2025.
Knops, Reinoud E., et al. “A Dual-Chamber Leadless Pacemaker.” New England Journal of Medicine (2023). DOI: 10.1056/NEJMoa2300080
Knops, R.E, Ph.D., Reddy, V.Y., Ip, J.E., Doshi, R.., et al. A Dual-Chamber Leadless Pacemaker. Published May 20, 2023. N Engl J Med 2023;388:2360-2370 DOI: 10.1056/NEJMoa2300080 VOL. 388 NO. 25 Copyright © 2023
Steinwender, C., Khelae, S. K. , Garweg, C., Chan, J. Y., C. et al. Atrioventricular Synchronous Pacing Using a Leadless Ventricular Pacemaker: Results From the MARVEL 2 Study. Publication: JACC: Clinical Electrophysiology. Volume 6, Number https://doi.org/10.1016/j.jacep.2019.10.017
Sutton R, Prakash A. Physiological Pacing: Historical Review With an Eye to the Future. J Cardiovasc Electrophysiol. 2025;36(3):665-672. doi:10.1111/jce.16559 https://pubmed.ncbi.nlm.nih.gov/39777766/
Fontana M, Berk JL, Gillmore JD, et al. Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy. N Engl J Med. 2025;392(1):33-44. doi:10.1056/NEJMoa2409134 https://pubmed.ncbi.nlm.nih.gov/39213194/
Gillmore JD, Judge DP, Cappelli F, et al. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2024;390(2):132-142. doi:10.1056/NEJMoa2305434 https://pubmed.ncbi.nlm.nih.gov/38197816/
Knops RE, Reddy VY, Ip JE, et al. A Dual-Chamber Leadless Pacemaker. N Engl J Med. 2023;388(25):2360-2370. doi:10.1056/NEJMoa2300080 https://pubmed.ncbi.nlm.nih.gov/37212442/
Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379(11):1007-1016. doi:10.1056/NEJMoa1805689 https://pubmed.ncbi.nlm.nih.gov/30145929/
Senman B, Jentzer JC, Barnett CF, et al. Need for a Cardiogenic Shock Team Collaborative-Promoting a Team-Based Model of Care to Improve Outcomes and Identify Best Practices. J Am Heart Assoc. 2024;13(6):e031979. doi:10.1161/JAHA.123.031979 https://pubmed.ncbi.nlm.nih.gov/38456417/
As Medical Director of Huntington Hospital, Dr. Cacciabaudo, oversees Medical Staff, Quality, Medical
Education, Radiology, Pharmacy and the Clinical Laboratory, Pathology and Blood Bank. She works collaboratively with nursing and hospital leadership in overseeing patient safety issues and standards of care at the 220-bed community hospital. She is proud of her team as Huntington Hospital is the only 5 Star CMS Hospital in Suffolk County. She has been a spokesperson for the American Heart Association for over 20 years and was a member of the Eastern States AHA Board of Directors. Throughout her career, she has been involved in research on the diagnosis and prevention of heart disease in women.
Previously, Dr. Cacciabaudo served as Medical Director of Peconic Bay Medical Center, Southside
Hospital’s Chief of Cardiology and Long Island Jewish Medical Center’s Associate Medical Director.
Under her leadership at Southside Hospital, she worked with the multidisciplinary team that brought
open heart surgery and advanced complex cardiac care to Suffolk County. She is the recipient of the
Northwell Health Truly Award in Mentorship recognizing her dedication to developing physicians and future physician leaders over the years. In 2019, she received the United Hospital Fund Excellence in Health Care Award for championing quality improvement. She also received the Northwell Health President’s Award in 2016 for Team Innovation. She chaired the Physician Engagement Committee in Northwell Health Physician Partners and brought physician star ratings and comments to the internet so that patients can have insight into what other patients are saying about their physicians.
Dr. Cacciabaudo received her medical training at New York Medical College and served as intern and resident at New York Hospital-Cornell Medical Center and Memorial Sloan Kettering Cancer Center, where her training also included clinical fellowships in hypertension and cardiology.
Board certifications
Internal Medicine – American Board of Internal Medicine
Cardiovascular Disease – American Board of IM / Cardiovascular Disease
Interventional Cardiology – American Board of IM / Interventional Cardiology
Administrative titles
Director – Interventional Cardiology – Huntington
Director – Interventional Cardiology of Cardiology, Huntington Hospital
Academic titles
Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Education
State University of New York (SUNY) at Buffalo
Residencies
Montefiore Medical Center – Moses Division
Fellowships
Hofstra Northwell School of Medicine
Hofstra Northwell School of Medicine
